// App-Quantinova.ai

: Nivoswitch trial: Predictive value of PD-L1 in plasma and extracellular vesicles.

Researchers

Presenter

  • JAdzia Sonnleithner

Principal Investigators

  • Dirk Himbert

  • Philip Zeuschner

  • Arndt Hartmann

  • Carsten Grüllich

  • Philipp Ivanyi

  • Manfred Wirth

  • Peter Staib

  • Martin Schostak

  • Philip Dargatz

  • Lothar Müller

  • Viktor Grünwald

  • Kerstin Junker

Medical Centers

  • University Hospital, Dept. of Urology, Essen, Germany

  • Department of Pediatric Radiology, Heidelberg University Hospital, Heidelberg, Germany

  • University Hospital Carl Gustav Carus, Technische Universitat, Dresden, Germany.

  • Medizinisch Hochschule Hannover, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Hannover, Germany

  • Saarland University, Dept. of Urology and Paediatric Urology, Homburg, Germany

  • Urology Department, Magdeburg University Hospital, Magdeburg, Germany

  • Institute of Clinical and Molecular Virology, Universitatsklinikum Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Germany

  • Klinik für Hämatologie und Onkologie, St.-Antonius Hospital, Eschweiler, Germany

  • Klinik für Hämatologie/Onkologie, Johannes Wesling Klinikum Minden, Minden, Germany

  • Studienzentrum UnterEms und Onkologie UnterEms, Leer, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Nivolumab

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02959554

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved